BioPharma Credit PLC
BPCR.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.08B
Close$
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $1.02 Billion |
| Dividend Yield | $0.10 (8.74%) |
| Earnings per Share | $0.11 |
| Beta | 0.23 |
| Outstanding Shares | 1,126,769,382 |
Return
| Return on Equity | 20.25% |
|---|---|
| Return on Assets | 20.19% |
| Return on Invested Capital | 3.21% |
Valuation & Multiples
| P/E Ratio | 10.14 |
|---|---|
| PEG | -32.94 |
| Price to Sales | - |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | 4.18 |
| Enterprise Value to EBIT | 27.76 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioPharma Credit PLC
15 employees
CEO: Pedro Gonzalez de Cosio Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from the sales of established life sciences products.